During a fireside chat at Reuters Pharma Europe 2025, Francesco Di Marco, Global Head of Human Pharma Regions at Boehringer ...

In a fitting embodiment of its own themes, this year, Reuters Pharma Europe 2025 is offering an AI-generated summary of each ...

Jazz Pharma has agreed to pay $145 million to settle lawsuits claiming it illegally acted to prevent generic versions of its ...

The FDA has approved Bristol Myers Squibb's Opdivo and Yervoy as first-line therapy for patients with a particular form of ...

The team from Cancer Research UK's Manchester Institute says it has created a new in vitro model of lung squamous cell ...

The US is dangerously close to falling behind China in biotech, and the government should spend a minimum of $15 billion over ...

At the same time that Donald Trump was saying that a "major tariff" on pharmaceuticals is coming to force more manufacturers ...

In this webinar – ‘Enabling Digitally Enhanced Care for Rare Diseases in Europe: Integrating AI and Connected Care ...

UK medtech company Brainomix has been granted FDA approval for a new feature for its artificial intelligence-powered stroke ...

AstraZeneca and Daiichi Sankyo have claimed approval from the European Commission for their TROP2-directed antibody-drug ...

The UK government has said it will invest up to £600 million ($764 million) in the creation of a centralised health data ...

The mRNA field is on the cusp of revolutionary change, with cancer vaccines, in vivo cell engineering and gene editing technologies unleashing the next advancements of therapeutic candidates and ...